Author

D. Forgacs

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Organism:mouse· 1 Organism:zebrafish· 1

Frequent Co-Authors

A. M. Jefferson· 2 shared H. B. Hanley· 2 shared H. Jang· 2 shared J. L. Gattiker· 2 shared T. M. Ross· 2 shared A. Colella· 1 shared A. G. Bebin-Blackwell· 1 shared A. Stella· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. M. Jefferson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The effect of waning on antibody levels and memory B cell recall following SARS-CoV-2 infection or vaccination

D. Forgacs, V. S. Moraes, H. B. Hanley, J. L. Gattiker, A. M. Jefferson, T. M. Ross

This study tracks antibody levels and memory B cell recall after SARS-CoV-2 infection or vaccination, finding that antibody waning occurs faster after vaccination than infection and that memory B cell recall can occur without detectable antibodies.

bioRxiv · Mar 16, 2022Immunology

Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection

L. Li, Y. Honda-Okubo, Y. Huang, H. Jang, M. A. Carlock, J. Baldwin, S. Piplani, A. G. Bebin-Blackwell, D. Forgacs, K. Sakamoto, A. Stella, S. Turville, T. Chataway, A. Colella, J. Triccas, , N. Petrovsky

This study develops a recombinant SARS-CoV-2 spike protein vaccine, Covax-19, formulated with Advax-SM adjuvant, showing protection against COVID-19 in mice and ferrets.

bioRxiv · Jul 3, 2021Immunology

Functional characterization of SARS-CoV-2 vaccine elicited antibodies in immunologically naive and pre-immune humans

D. Forgacs, H. Jang, R. B. Abreu, H. B. Hanley, J. L. Gattiker, A. M. Jefferson, T. M. Ross

This study compares antibody responses to SARS-CoV-2 vaccination in pre-immune and immunologically naive individuals, finding higher neutralizing antibody levels in pre-immune participants.

bioRxiv · May 29, 2021Immunology